PMGC Holdings Inc. (ELAB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.28M
Last updated: Nov 17, 2026 at 11:04 AM ET
PMGC Holdings Inc. (ELAB) Competitors
The companies most similar to PMGC Holdings are Enlivex Therapeutics (ENLV), GeoVax Labs (GOVX) and Silexion Therapeutics (SLXN). By market cap, PMGC Holdings ranks 10th of the 13 companies on this page; Bioatla (BCAB) is the largest at $2.89M.
Peer Comparison
ELAB's revenue growth of -45.8% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| PMGC Holdings (ELAB) | $1.28M | N/A | 0.3x | 0.0% | -40.3% | -45.8% | 0.00% |
| Enlivex Therapeutics Ltd (ENLV) | $1.82M | N/A | N/A | 0.0% | -0.3% | 0.0% | 0.00% |
| GeoVax Labs Inc (GOVX) | $928290 | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Silexion Therapeutics Corp (SLXN) | $1.29M | N/A | 5.9x | 0.0% | N/A | 0.0% | 0.00% |
| Kairos Pharma, Ltd. (KAPA) | $1.54M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Scinai Immunotherapeutics Ltd (SCNI) | $1.05M | N/A | N/A | -80.1% | N/A | 572.0% | 0.00% |
| Virax Biolabs Group Limited Ordinary Shares (VRAX) | $823940 | N/A | 14.3x | 0.0% | N/A | 685.0% | 0.00% |
| Revelation Biosciences Inc (REVB) | $2.43M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| VivoSim Labs, Inc. (VIVS) | $2.58M | N/A | 15.1x | 0.0% | N/A | -51.4% | 0.00% |
| Bioatla Inc (BCAB) | $2.89M | N/A | N/A | 0.0% | N/A | 31.6% | 0.00% |
| Calidi Biotherapeutics Inc. (CLDI) | $2.29M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Genprex Inc (GNPX) | $1.71M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Onconetix Inc (ONCO) | $2.15M | N/A | 1.0x | 0.0% | N/A | -83.9% | 0.00% |
| Peer median | $1.76M | N/A | 10.1x | 0.0% | -0.3% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to PMGC Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Enlivex Therapeutics Ltd (ENLV) | Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel. | ENLV competitors |
| GeoVax Labs Inc (GOVX) | GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified... | GOVX competitors |
| Silexion Therapeutics Corp (SLXN) | Biomotion Sciences (SLXN) is a forward-thinking biotechnology firm specializing in regenerative medicine... | SLXN competitors |
| Kairos Pharma, Ltd. (KAPA) | Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients. | KAPA competitors |
| Scinai Immunotherapeutics Ltd (SCNI) | Scinai Immunotherapeutics Ltd is an innovative biotechnology company focused on developing cutting-edge immunotherapy solutions for cancer and autoimmune... | SCNI competitors |
| Virax Biolabs Group Limited Ordinary Shares (VRAX) | Virax Biolabs Group Limited, a biotechnology company, sells, distributes and markets diagnostic test kits and medical technology products and PPE... | |
| Revelation Biosciences Inc (REVB) | Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics... | REVB competitors |
| VivoSim Labs, Inc. (VIVS) | VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. | VIVS competitors |
| Bioatla Inc (BCAB) | BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. | BCAB competitors |
| Calidi Biotherapeutics Inc. (CLDI) | Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. | CLDI competitors |
| Genprex Inc (GNPX) | Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. | GNPX competitors |
| Onconetix Inc (ONCO) | Onconetix Inc. is a cutting-edge biotechnology firm committed to revolutionizing cancer care with its innovative diagnostic and therapeutic solutions. | ONCO competitors |
Frequently Asked Questions About ELAB
Who are PMGC Holdings' main competitors?
The companies most similar to PMGC Holdings include Enlivex Therapeutics (ENLV), GeoVax Labs (GOVX), Silexion Therapeutics (SLXN), Kairos Pharma (KAPA) and Scinai Immunotherapeutics (SCNI), listed from the closest match.
Who is PMGC Holdings' biggest competitor?
Bioatla (BCAB) is the largest of the similar companies at $2.89M; Enlivex Therapeutics (ENLV) is the closest match by business profile, size, sector and industry.
How does ELAB stock compare with its competitors?
ELAB's P/S is 0.3x against a peer median of 10.1x; its net margin is 0.0% against a peer median of 0.0%.
Which of PMGC Holdings' competitors pays a higher dividend?
PMGC Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is PMGC Holdings bigger than its competitors?
No. PMGC Holdings is 10th by market cap among the 13 companies on this page; the largest is Bioatla (BCAB) at $2.89M.
ELAB pages: Overview, Financials, Valuation, Competitors